Cetecal D
Natural health product licensed in Canada
- Licence holder
- Euro-Pharm International Canada Inc.
- NPN or DIN-HM
- 80003626
- Status
- Inactive licence
- Licence date
- 21 June 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 6.25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine D Potency : 125 UI | 3.125 mcg | 6.25 µg |
Non-medicinal ingredients
Croscarmellose de sodium, Béhénate de glycéryle, Cellulose, microcristalline, Dioxyde de silicium colloïdal, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | Not specified | 1 Comprimé | 2 Tous les jours |
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
| Adultes (enceintes et/ou allaitantes) | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Calcium supplement with vitamin D. Helps in the normal development and maintenance of bones and teeth, especially in infancy and childhood. Helps to prevent bone resorption and osteoporosis. Helps in the absorption and use of calcium and phosphorous. It is a factor in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid using two (2) hours prior to or until four (4) hours after taking other medications.
Source
Official Health Canada record, licence 80003626
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.